Sweetless'n low LDL-C targets for PCSK9 treatment

Eur Heart J. 2015 May 14;36(19):1146-8. doi: 10.1093/eurheartj/ehv056. Epub 2015 Mar 31.

Authors

Baris Gencer¹, François Mach²

Affiliations

¹ Cardiology Division, Department of Specialties in Medicine, Geneva University Hospitals, Switzerland.
² Cardiology Division, Department of Specialties in Medicine, Geneva University Hospitals, Switzerland francois.mach@hcuge.ch.

PMID: 25827601
DOI: 10.1093/eurheartj/ehv056

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal / administration & dosage*
Anticholesteremic Agents / administration & dosage*
Cardiovascular Diseases / prevention & control*
Female
Humans
Hypercholesterolemia / drug therapy*
Male

Substances

Antibodies, Monoclonal
Anticholesteremic Agents